These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11846434)

  • 1. Synthesis of RGD analogs as potential vectors for targeted drug delivery.
    Jiang J; Wang W; Sane DC; Wang B
    Bioorg Chem; 2001 Dec; 29(6):357-79. PubMed ID: 11846434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE
    Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists.
    Wang W; Borchardt RT; Wang B
    Curr Med Chem; 2000 Apr; 7(4):437-53. PubMed ID: 10702618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban.
    Mousa SA; Bozarth JM; Naik UP; Slee A
    Br J Pharmacol; 2001 Jun; 133(3):331-6. PubMed ID: 11375248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
    J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
    Savi P; Zamboni G; Rescanières O; Herbert JM
    Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
    Murphy NP; Pratico D; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):945-51. PubMed ID: 9694954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system.
    Gupta AS; Huang G; Lestini BJ; Sagnella S; Kottke-Marchant K; Marchant RE
    Thromb Haemost; 2005 Jan; 93(1):106-14. PubMed ID: 15630499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
    Krysko AA; Samoylenko GV; Polishchuk PG; Andronati SA; Kabanova TA; Khristova TM; Kuz'min VE; Kabanov VM; Krysko OL; Varnek AA; Grygorash RY
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5971-4. PubMed ID: 21852128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional quantitative structure-activity relationship analyses of RGD mimetics as fibrinogen receptor antagonists.
    Miyashita M; Akamatsu M; Hayashi Y; Ueno T
    Bioorg Med Chem Lett; 2000 May; 10(9):859-63. PubMed ID: 10853647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
    Marciniak SJ; Jordan RE; Mascelli MA
    Thromb Haemost; 2001 Mar; 85(3):539-43. PubMed ID: 11307828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation to hyperbranched polyglycerols improves RGD-mediated inhibition of platelet function in vitro.
    Zhang JG; Krajden OB; Kainthan RK; Kizhakkedathu JN; Constantinescu I; Brooks DE; Gyongyossy-Issa MI
    Bioconjug Chem; 2008 Jun; 19(6):1241-7. PubMed ID: 18476729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
    Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
    J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of amidino-tyrosine derivatives as non-peptide fibrinogen receptor antagonists.
    Xu TL; Jiang XT; Hua WY; Ni PZ; Pei YM
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1933-6. PubMed ID: 10450956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
    Krysko AA; Krysko OL; Kabanova TA; Andronati SA; Kabanov VM
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4444-6. PubMed ID: 20598885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion.
    Wang X; Dorsam RT; Lauver A; Wang H; Barbera FA; Gibbs S; Varon D; Savion N; Friedman SM; Feuerstein GZ
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1114-20. PubMed ID: 12438534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.